GRDN · Guardian Pharmacy Services, Inc. · Executive Compensation

$49.52 +0.14 (+0.28%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript

Russell 2000 member Rebalance outlook locked

Market Cap

$3.14B

63.35M

Volume · Nov 13 339.13K Avg daily vol (3M) 534.7K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Morris	Executive Vice President and Chief Financial Officer	$412,000	—	$239,997	—	$309,000	$35,707	$996,704
Kendall Forbes	Executive Vice President, Sales & Operations	$412,000	—	$239,997	—	$309,000	$33,737	$994,734
Fred Burke	President and Chief Executive Officer	$463,500	—	—	—	$347,625	$34,717	$845,842

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Fred Burke	President and Chief Executive Officer	$450,000	—	—	—	$270,000	$46,103	$766,103
David Morris	Executive Vice President and Chief Financial Officer	$400,000	—	—	—	$240,000	$44,317	$684,317
Kendall Forbes	Executive Vice President, Sales & Operations	$400,000	—	—	—	$240,000	$41,050	$681,050

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Fred Burke	President and Chief Executive Officer	$402,750	—	—	—	$212,625	$58,362	$673,737
David Morris	Executive Vice President and Chief Financial Officer	$348,625	—	—	—	$184,313	$54,386	$587,324
Kendall Forbes	Executive Vice President, Sales & Operations	$348,625	—	—	—	$184,313	$50,687	$583,625

Executive changes

Person	Role	Change	Effective	Filed
Will Mudd	Senior Vice President and Chief Financial Officer	Appointed	2026-07-01	2026-06-22
David Morris	Executive Vice President, Chief Operating Officer	Appointed	2026-07-01	2026-06-22
Kendall Forbes	Executive Vice President of Sales & Operations	Retired	2026-07-01	2026-06-22
Thomas Salentine, Jr.	Director (Bindley Capital Nominee)	Appointed	2024-09-25	2024-09-30
Mary Sue Patchett	Director	Appointed	2024-09-25	2024-09-30
Randall Lewis	Director	Appointed	2024-09-25	2024-09-30
Steve Cosler	Director	Appointed	2024-09-25	2024-09-30
John Ackerman	Director (Cardinal Stockholders Nominee)	Appointed	2024-09-25	2024-09-30
William Bindley	Director (Bindley Capital Nominee)	Appointed	2024-09-25	2024-09-30

Leadership

David K. Morris CFO
Will Mudd CFO
David Morris COO
John Ackerman Board Member
Randall Lewis Board Member
Steve Cosler Board Member
Thomas Salentine, Jr. Board Member
William Bindley Board Member

Key facts CIK 1802255 CUSIP 40145W101 13F (30d) 137 filings 133 filers Visit website Investor relations